off-label use of glp-1 agonists for obesity in 2016 Nutritional priorities to support therapy obesity: a joint Advisory from the American College Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and The Obesity Society Harnessing GLP-1 Receptor Agonists for

adults are at risk of at least one mineral deficiency, most commonly magnesium or zinc (NIH 2023)

These resources include: A CISP Checklist Implementing Revised List (available now) Athlete and Athlete Support Personnel (ASP) Factsheet on Glucocorticoids (to be available in October) Medical Professionals Factsheet on Glucocorticoids (to be available in the coming weeks) Athlete and ASP Guide to the 2022 List (to be available from 1 January 2022) Upcoming Webinar In order to further assist stakeholders in their understanding and implementation of the 2022 List, WADA will host a webinar in November 2021

This summer has taught me how to transition from an undergraduate student to a full-time researcher

This compounded injectable formulation has not been reviewed or approved by the U.S